NCT01682044
- Conditions
- Chronic Disease, Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, +51 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
Clinical trial condition
Explore clinical trials studying Stage III Marginal Zone Lymphoma. Study availability and eligibility vary by location and protocol.
NCT01682044
NCT00112593
NCT00795769
NCT00244855
NCT00049504
NCT00408681
NCT01959477
NCT00608361
NCT01158274